The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase

Malte Bachmann1, Christian Kosan, Pei Xiang Xing

  • 1Institut für Zellbiologie (Tumorforschung), IFZ, Universitätsklinikum Essen, Virchowstrasse 173, D-45122 Essen, Germany.

Insights

The proto-oncogene Pim-1 kinase directly phosphorylates and activates Cdc25C phosphatase. This interaction promotes cell cycle progression at the G2/M transition, highlighting Pim-1

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Oncogenesis

Background:

  • The proto-oncogene Pim-1 is a serine-threonine kinase involved in cytokine signaling and cell cycle progression.
  • Pim-1 influences cell cycle regulators including p21(Waf), Cdc25A, and C-TAK1.
  • Cdc25C phosphatase regulates the G2/M cell cycle transition and can be inactivated by C-TAK1.

Purpose of the Study:

  • To investigate the interaction between Pim-1 and Cdc25C.
  • To determine if Pim-1 directly phosphorylates Cdc25C.
  • To elucidate the functional consequence of Pim-1 phosphorylation on Cdc25C activity and cell cycle progression.

Main Methods:

  • Biochemical assays to assess protein-protein interactions and phosphorylation.
  • Immuno-fluorescence microscopy to determine subcellular localization of Pim-1 and Cdc25C.
  • Cell transfection and G2/M cell cycle arrest using bleomycin to evaluate cell cycle progression.

Main Results:

  • Pim-1 directly interacts with and phosphorylates the N-terminal region of Cdc25C.
  • Pim-1 and Cdc25C co-localize in the cytoplasm of epithelial and myeloid cells.
  • Phosphorylation by Pim-1 enhances Cdc25C phosphatase activity, promoting G2/M to G1 progression in bleomycin-arrested cells.

Conclusions:

  • Pim-1 directly activates Cdc25C phosphatase through phosphorylation.
  • Pim-1 functions as a positive regulator of the cell cycle at the G2/M transition.
  • This mechanism provides a novel insight into Pim-1's role in cell cycle control and oncogenesis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...